LifeScience Clinical & Diagnostic

Antengene's ATG-022 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers

Orphan Drugs, also known as Rare Disease Drugs, refers to pharmaceutical products developed for the prevention, diagnosis, and treatment of rare diseases o...

 May 24, 2023 | News

Asieris and UroViu Strengthen Partnership for Bladder Cancer Diagnosis and Treatment Platform

Under the agreement, Asieris Pharmaceuticals will use this patented technology in combination with specific optical imaging agents to conduct research on t...

 May 19, 2023 | News

Hummingbird Bioscience, Merck to Evaluate HMBD-001 in Lung Carcinoma

Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 ...

 May 16, 2023 | News

CytoMed collaborates with MD Anderson to advance Gamma Delta T Cells in Oncology

CytoMed Therapeutics Limited (Nasdaq: GDTC) ("CytoMed" or the "Company"), a biopharmaceutical company focused on harnessing its licensed proprietary techno...

 May 11, 2023 | News

Lucence Launches LucenceINSIGHT to Detect Cancer Earlier

Lucence achieved a significant milestone in February 2023 as the first Asian company to secure Medicare coverage in the US for LiquidHALLMARK, its Singapor...

 May 11, 2023 | News

Thermo Fisher & Pfizer team up to bring cancer testing to global markets

Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access t...

 May 10, 2023 | News

Singapore Approves New Therapy for Rare Gastrointestinal Stromal Tumors

Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST QINLO...

 May 08, 2023 | News

Cellenkos Doses First Patient with CK0803 Cell Therapy for ALS Treatment

Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory cell therapies for treatment...

 May 03, 2023 | News

Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment

MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...

 May 02, 2023 | News

FDA Approves Teva and MedinCell's UZEDY™ for Adult Schizophrenia Treatment

This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a ...

 May 01, 2023 | Regulatory

Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2023

  –Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organ...

 May 01, 2023 | News

Toshiba's Heavy Ion Therapy System treats patients at Yonsei University Health System.

Toshiba Energy Systems & Solutions Corporation (hereinafter "Toshiba ESS") is pleased to announce today the commencement of treatment using a heavy ion...

 April 30, 2023 | News

Gene Solutions' multi-cancer early detection shows promise in Southeast Asia's biotech industry.

Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...

 April 26, 2023 | News

SCG Cell Therapy to Highlight Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma at ISCT

"These exciting new data being presented at ISCT continue to reinforce the potential for viral antigen specific TCR-T product to effectively treat infectio...

 April 24, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close